PW Medtech Group
Market Cap
HK$910.2m
Last Updated
2021/01/23 10:25 UTC
Data Sources
Company Financials
Executive Summary
PW Medtech Group Limited, an investment holding company, operates as a medical device company in the People’s Republic of China. More Details
Rewards
Risk Analysis
Snowflake Analysis
Adequate balance sheet and fair value.
Share Price & News
How has PW Medtech Group's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: 1358 is more volatile than 90% of Hong Kong stocks over the past 3 months, typically moving +/- 22% a week.
Volatility Over Time: 1358's weekly volatility has increased from 12% to 22% over the past year.
Market Performance
7 Day Return
1.8%
1358
10.9%
HK Medical Equipment
3.5%
HK Market
1 Year Return
-56.4%
1358
113.9%
HK Medical Equipment
15.1%
HK Market
Return vs Industry: 1358 underperformed the Hong Kong Medical Equipment industry which returned 113.9% over the past year.
Return vs Market: 1358 underperformed the Hong Kong Market which returned 15.1% over the past year.
Shareholder returns
| 1358 | Industry | Market | |
|---|---|---|---|
| 7 Day | 1.8% | 10.9% | 3.5% |
| 30 Day | -73.3% | 12.5% | 12.7% |
| 90 Day | -65.5% | 20.7% | 18.1% |
| 1 Year | 37.4%-56.4% | 117.3%113.9% | 19.7%15.1% |
| 3 Year | 16.4%-63.1% | 223.3%207.7% | -5.1%-15.1% |
| 5 Year | 11.4%-64.6% | 353.3%314.9% | 65.1%37.0% |
Long-Term Price Volatility Vs. Market
How volatile is PW Medtech Group's share price compared to the market and industry in the last 5 years?
Simply Wall St News
3 weeks ago | Simply Wall St
Here's Why PW Medtech Group (HKG:1358) Can Manage Its Debt Responsibly1 month ago | Simply Wall St
Should You Be Adding PW Medtech Group (HKG:1358) To Your Watchlist Today?2 months ago | Simply Wall St
What You Need To Know About PW Medtech Group Limited's (HKG:1358) Investor CompositionValuation
Is PW Medtech Group undervalued compared to its fair value and its price relative to the market?
4.66x
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: 1358 (HK$0.58) is trading above our estimate of fair value (HK$0.13)
Significantly Below Fair Value: 1358 is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: 1358 is good value based on its PE Ratio (4.7x) compared to the HK Medical Equipment industry average (29.9x).
PE vs Market: 1358 is good value based on its PE Ratio (4.7x) compared to the Hong Kong market (11.9x).
Price to Earnings Growth Ratio
PEG Ratio: Insufficient data to calculate 1358's PEG Ratio to determine if it is good value.
Price to Book Ratio
PB vs Industry: 1358 is good value based on its PB Ratio (0.2x) compared to the HK Medical Equipment industry average (3.9x).
Next Steps
Future Growth
How is PW Medtech Group forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?
35.3%
Forecasted Healthcare industry annual growth in earnings
In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as PW Medtech Group has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.
This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.
Next Steps
- Examine whether PW Medtech Group is trading at an attractive price based on how much it is expected to earn in the future, and relative to its industry peers and the wider market.
- PW Medtech Group competitive advantages and company strategy can generally be found in its financial reports archived here.
- Explore growth companies in the Healthcare industry.
Past Performance
How has PW Medtech Group performed over the past 5 years?
-15.2%
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: 1358 has a large one-off gain of CN¥51.4M impacting its June 30 2020 financial results.
Growing Profit Margin: 1358's current net profit margins (56%) are higher than last year (40%).
Past Earnings Growth Analysis
Earnings Trend: 1358's earnings have declined by 15.2% per year over the past 5 years.
Accelerating Growth: 1358's earnings growth over the past year (20%) exceeds its 5-year average (-15.2% per year).
Earnings vs Industry: 1358 earnings growth over the past year (20%) exceeded the Medical Equipment industry 17.7%.
Return on Equity
High ROE: 1358's Return on Equity (3.4%) is considered low.
Next Steps
Financial Health
How is PW Medtech Group's financial position?
Financial Position Analysis
Short Term Liabilities: 1358's short term assets (CN¥515.5M) exceed its short term liabilities (CN¥142.8M).
Long Term Liabilities: 1358's short term assets (CN¥515.5M) exceed its long term liabilities (CN¥20.2M).
Debt to Equity History and Analysis
Debt Level: 1358's debt to equity ratio (0.2%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if 1358's debt to equity ratio has reduced over the past 5 years.
Debt Coverage: 1358's debt is well covered by operating cash flow (1184%).
Interest Coverage: 1358's interest payments on its debt are not well covered by EBIT (0.3x coverage).
Balance Sheet
Next Steps
Dividend
What is PW Medtech Group current dividend yield, its reliability and sustainability?
Dividend Yield vs Market
Notable Dividend: Unable to evaluate 1358's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate 1358's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if 1358's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if 1358's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of 1358's dividend in 3 years as they are not forecast to pay a notable one for the Hong Kong market.
Next Steps
Management
How experienced are the management team and are they aligned to shareholders interests?
1.6yrs
Average management tenure
CEO
Yue'e Zhang (57 yo)
1.83yrs
Tenure
CN¥1,039,000
Compensation
Ms. Yue'e Zhang has been Chief Executive Officer at PW Medtech Group Ltd. since March 31, 2019. Ms. Zhang serves as a General Manager, Senior Engineer and Executive Director of WP Medical Technologies, Inc...
CEO Compensation Analysis
Compensation vs Market: Yue'e's total compensation ($USD160.30K) is below average for companies of similar size in the Hong Kong market ($USD230.79K).
Compensation vs Earnings: Yue'e's compensation has been consistent with company performance over the past year.
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & CEO | 1.83yrs | CN¥1.04m | 0.0032% CN¥ 29.0k | |
| Financial Director | 1yr | no data | no data | |
| Company Secretary | 1.58yrs | no data | no data |
1.6yrs
Average Tenure
37yo
Average Age
Experienced Management: 1358's management team is not considered experienced ( 1.6 years average tenure), which suggests a new team.
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman & CEO | 1.83yrs | CN¥1.04m | 0.0032% CN¥ 29.0k | |
| Independent Non-Executive Director | 7.25yrs | CN¥177.00k | no data | |
| Independent Non-Executive Director | 7.25yrs | CN¥177.00k | 0.041% CN¥ 369.4k | |
| Independent Non-Executive Director | 7.25yrs | CN¥177.00k | no data | |
| Non-Executive Director | 7.58yrs | CN¥692.00k | 0.17% CN¥ 1.5m | |
| Non-Executive Director | 7.58yrs | CN¥300.00k | 0.11% CN¥ 970.6k |
7.3yrs
Average Tenure
55yo
Average Age
Experienced Board: 1358's board of directors are considered experienced (7.3 years average tenure).
Ownership
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Recent Insider Transactions
Ownership Breakdown
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Top Shareholders
Company Information
PW Medtech Group Limited's company bio, employee growth, exchange listings and data sources
Key Information
- Name: PW Medtech Group Limited
- Ticker: 1358
- Exchange: SEHK
- Founded: 1997
- Industry: Health Care Equipment
- Sector: Healthcare
- Market Cap: HK$910.163m
- Shares outstanding: 1.57b
- Website: https://www.pwmedtech.com
Number of Employees
Location
- PW Medtech Group Limited
- Building 1
- No. 23 Panlong West Road
- Beijing
- Beijing Province
- 101204
- China
Listings
| Ticker | Exchange | Primary Security | Security Type | Country | Currency | Listed on |
|---|---|---|---|---|---|---|
| 1358 | SEHK (The Stock Exchange of Hong Kong Ltd.) | Yes | Ordinary Shares | HK | HKD | Nov 2013 |
| PWE | DB (Deutsche Boerse AG) | Yes | Ordinary Shares | DE | EUR | Nov 2013 |
Biography
PW Medtech Group Limited, an investment holding company, operates as a medical device company in the People’s Republic of China. It manufactures and sells infusion sets, such as non-PVC-based infusion sets...
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2021/01/23 10:25 |
| End of Day Share Price | 2021/01/22 00:00 |
| Earnings | 2020/06/30 |
| Annual Earnings | 2019/12/31 |
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.